Previous studies have reported the possible involvement of thioredoxin system dysregulation in the pathogenesis of glaucoma [41], [42], [51]–[53]; thus, measurement of the thioredoxin level separately from the other thiol groups should be done in the future. The gene discussed is TXN; the disease is glaucoma.